Jinjing Xia

474 total citations
14 papers, 354 citations indexed

About

Jinjing Xia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jinjing Xia has authored 14 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Jinjing Xia's work include Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jinjing Xia is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jinjing Xia collaborates with scholars based in China and United States. Jinjing Xia's co-authors include Yayou Miao, Xiaoting Tian, Yikun Wang, Lifang Ma, Shiyu Qiu, Jiangtao Cui, Xin Xu, Yongchun Yu, Jiayi Wang and Keke Yu and has published in prestigious journals such as Free Radical Biology and Medicine, International Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

Jinjing Xia

13 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjing Xia China 8 250 172 171 77 21 14 354
Shiye Ruan China 8 380 1.5× 239 1.4× 91 0.5× 91 1.2× 24 1.1× 13 466
Xiaoxuan Zhong China 9 246 1.0× 176 1.0× 179 1.0× 31 0.4× 8 0.4× 11 358
Jinkai Wan China 3 180 0.7× 113 0.7× 66 0.4× 54 0.7× 17 0.8× 4 278
Jingwan Zhou China 6 225 0.9× 181 1.1× 111 0.6× 31 0.4× 6 0.3× 7 307
Binshen Chen China 8 211 0.8× 89 0.5× 87 0.5× 44 0.6× 7 0.3× 22 329
Guifeng Sun China 4 239 1.0× 151 0.9× 79 0.5× 31 0.4× 21 1.0× 4 283
Pingting Ying China 10 275 1.1× 128 0.7× 27 0.2× 45 0.6× 32 1.5× 17 321
Senxu Lu China 9 401 1.6× 316 1.8× 37 0.2× 48 0.6× 19 0.9× 9 460
Paz Nombela Spain 2 377 1.5× 247 1.4× 77 0.5× 71 0.9× 20 1.0× 2 433

Countries citing papers authored by Jinjing Xia

Since Specialization
Citations

This map shows the geographic impact of Jinjing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjing Xia more than expected).

Fields of papers citing papers by Jinjing Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjing Xia. The network helps show where Jinjing Xia may publish in the future.

Co-authorship network of co-authors of Jinjing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjing Xia. A scholar is included among the top collaborators of Jinjing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjing Xia. Jinjing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Wu, Yi‐Long, Shun Lü, Gongyan Chen, et al.. (2024). IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer. Chinese Journal of Cancer Research. 36(2). 103–113. 2 indexed citations
3.
Hu, Yaohua, Jianlin Xu, Rong Qiao, et al.. (2023). Multi‐target angiogenesis inhibitor combined with PD‐1 inhibitors may benefit advanced non‐small cell lung cancer patients in late line after failure of EGFR‐TKI therapy. International Journal of Cancer. 153(3). 635–643. 21 indexed citations
4.
5.
Yu, Wenjun, Congcong Zhang, Yikun Wang, et al.. (2022). YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma. Cancer Gene Therapy. 30(1). 149–162. 23 indexed citations
6.
Ma, Lifang, Xiangfei Xue, Xiao Zhang, et al.. (2022). The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 36–36. 83 indexed citations
7.
Zhang, Congcong, Jiangtao Cui, Xiaoting Tian, et al.. (2022). ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 26(19). 5078–5094. 9 indexed citations
8.
Ma, Lifang, Xiao Zhang, Keke Yu, et al.. (2021). Targeting SLC3A2 subunit of system XC− is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Free Radical Biology and Medicine. 168. 25–43. 140 indexed citations
9.
Zhou, Yan, Hao Bai, Jinjing Xia, et al.. (2021). Novel ETV1 mutation in small cell lung cancer transformation resistant to EGFR tyrosine kinase inhibitors. Annals of Translational Medicine. 9(14). 1150–1150. 13 indexed citations
10.
Bai, Hao, et al.. (2019). Detection of EGFR mutations using target capture sequencing in plasma of patients with non-small-cell lung cancer. Journal of Clinical Pathology. 72(5). 379–385. 5 indexed citations
11.
Xiong, Liwen, Yuqing Lou, Hao Bai, et al.. (2019). Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients. Journal of International Medical Research. 48(4). 1219686827–1219686827. 32 indexed citations
12.
Xia, Jinjing, Hao Bai, Bo Yan, et al.. (2017). Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer. Oncotarget. 8(65). 108522–108533. 15 indexed citations
13.
Zhang, Tongtao, Aritra Chowdhury, Jinjing Xia, et al.. (2016). From Image to Translation. ACM Transactions on Asian and Low-Resource Language Information Processing. 15(4). 1–16. 1 indexed citations
14.
Xia, Jinjing, et al.. (2009). [The Clinical Analysis of 21 Patients with Lymphoepithelioma-like Carcinoma after Operation.].. PubMed. 12(11). 1169–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiye Ruan Breakdown of academic impact, for papers by Xiaoxuan Zhong Breakdown of academic impact, for papers by Jinkai Wan Breakdown of academic impact, for papers by Jingwan Zhou Breakdown of academic impact, for papers by Binshen Chen Breakdown of academic impact, for papers by Guifeng Sun Breakdown of academic impact, for papers by Pingting Ying Breakdown of academic impact, for papers by Senxu Lu Breakdown of academic impact, for papers by Paz Nombela
Rankless by CCL
2026